The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Multidisciplinary Care Pathways for Long COVID Fatigue:

A Systems-Based Model Integrating Rehabilitation Medicine, Neuroimmunology, Autonomic Care, and Precision Phenotyping Abstract Background Long COVID, also referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as one […]

Persistent SARS-CoV-2 Reservoirs and the Pathobiology of Long COVID

Etiology, Tissue Persistence, Genomics, Clinical Manifestations, Biomarkers, and Emerging Therapeutic Strategies John Murphy, Chief Executive Officer, The COVID-19 Long-haul Foundation Abstract Background More than four years after the emergence of […]

Long COVID and Renal Disease: Pathophysiology, Genomics, Clinical Manifestations, and Long-Term Implications

Abstract Long coronavirus disease (Long COVID, post-acute sequelae of SARS-CoV-2 infection [PASC]) has emerged as a major chronic health challenge affecting multiple organ systems. Although pulmonary, cardiovascular, and neurologic manifestations […]

The Molecular Genomics of SARS-CoV-2: An Integrated Multi-Omics Perspective on Viral Evolution, Genome Organization, Replication, Host Interaction, and Systems Biology

John Murphy, CEO The COVID19 Long-haul Foundation Abstract The emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) fundamentally transformed modern virology, molecular genetics, systems biology, structural biology, immunology, and […]

đź§  Neurovascular Dysregulation and Microclot Persistence in COVID-19 Long-Haul Illnesses

Author: John Murphy, President, COVID-19 Long-haul Foundation đź“‘ Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), affects millions globally and presents with persistent symptoms including fatigue, cognitive dysfunction, […]

The Lingering Pandemic: Mapping the Arc of Long COVID and the Search for Recovery

By John Murphy, The COVID 19 Long-haul Foundation Introduction: A Pandemic That Didn’t End When the world first confronted SARS-CoV-2 in early 2020, the prevailing narrative was one of acute […]